Cargando…

Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab

BACKGROUND: Pneumocystis pneumonia (PCP) is a life-threatening fungal infection that can occur in kidney transplantation (KT) recipients. A growing number of KT recipients are receiving perioperative treatment with rituximab, which is associated with prolonged B-cell depletion and possible risk of P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young Hoon, Kim, Jee Yeon, Kim, Dong Hyun, Ko, Youngmin, Choi, Ji Yoon, Shin, Sung, Jung, Joo Hee, Park, Su-Kil, Kim, Sung-Han, Kwon, Hyunwook, Han, Duck Jong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066802/ https://www.ncbi.nlm.nih.gov/pubmed/32160881 http://dx.doi.org/10.1186/s12882-020-01750-8

Ejemplares similares

Outcomes of Living-Donor Kidney Transplantation in Female Recipients with Possible Pregnancy-Related Pre-Sensitization According to Donor Relationship
por: Kim, Jee Yeon, et al.
Publicado: (2020)

401. Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients After a 6-Month Trimethoprim–Sulfamethoxazole Prophylaxis: A Case–Control Study
por: Park, Se Yoon, et al.
Publicado: (2018)

Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations
por: Ko, Youngmin, et al.
Publicado: (2020)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2020)

Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment
por: Lee, Hayoung, et al.
Publicado: (2022)

Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study
por: Kwon, Hyunwook, et al.
Publicado: (2019)

Effect of arteriovenous access closure and timing on kidney function in kidney transplant recipients
por: Jeong, Seonjeong, et al.
Publicado: (2019)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

Pure T-cell mediated rejection following kidney transplant according to response to treatment
por: Kwon, Hyunwook, et al.
Publicado: (2021)

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
por: Kim, Tark, et al.
Publicado: (2012)

1106. The incidence and risk factors associated with varicella zoster virus infection in kidney transplant recipients after 1-month acyclovir prophylaxis in a CMV preemptive therapy era
por: Kim, Haein, et al.
Publicado: (2020)

Long-Term Outcome of Live Kidney Donation in South Korea
por: Kim, Jee Yeon, et al.
Publicado: (2020)

Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation
por: Kwon, Hye Eun, et al.
Publicado: (2023)

A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients
por: Ko, Youngmin, et al.
Publicado: (2023)

Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant
por: Chapman, Fiona A., et al.
Publicado: (2019)

Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea
por: Kim, Tark, et al.
Publicado: (2015)

Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Lee, Su Hwan, et al.
Publicado: (2017)

Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
por: Goto, Norihiko, et al.
Publicado: (2017)

Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group
por: Song, Young Hae, et al.
Publicado: (2012)

Quantitation of BK Virus DNA for Diagnosis of BK Virus-Associated Nephropathy in Renal Transplant Recipients
por: Sung, Heungsup, et al.
Publicado: (2008)

Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis
por: Jiang, Xuqin, et al.
Publicado: (2015)

Shock Duration after Resuscitation Is Associated with Occurrence of Post-Cardiac Arrest Acute Kidney Injury
por: Kim, Yong Won, et al.
Publicado: (2015)

Association of duration of undernutrition with occurrence of tuberculosis
por: Park, Jiho, et al.
Publicado: (2022)

Analysis of 4000 kidney transplantations in a single center: Across immunological barriers
por: Kwon, Hyunwook, et al.
Publicado: (2016)

Association between post-transplant red cell distribution width and prognosis of kidney transplant recipients
por: Park, Sehoon, et al.
Publicado: (2017)

2144. Duration of perioperative antibiotic prophylaxis in ventriculoperitoneal shunt surgery in children
por: Tada, Ayumi, et al.
Publicado: (2022)

Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient: a case report
por: Jang, Hye-Won, et al.
Publicado: (2021)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab
por: Baek, Chung Hee, et al.
Publicado: (2015)

The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study
por: Singh, Ramandeep, et al.
Publicado: (2016)

Histopathology of Pneumocystis carinii pneumonia in immunocompetent laboratory rats
por: KIM, HYUN-SOO, et al.
Publicado: (2014)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
por: Han, Seung Seok, et al.
Publicado: (2012)

Late-Onset Granulomatous Pneumocystis jirovecii Pneumonia in A Renal Transplant Recipient: A Clinical Grand Round Conference Case in 2022
por: Baek, Yae Jee, et al.
Publicado: (2023)

Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
por: Kwon, Ji-Soo, et al.
Publicado: (2017)

Different antibody responses between liver and kidney transplant recipients elicited by third doses of COVID-19 mRNA vaccines
por: Lim, So Yun, et al.
Publicado: (2023)

Pneumocystis Pneumonia in Solid-Organ Transplant Recipients
por: Iriart, Xavier, et al.
Publicado: (2015)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia
por: Heffelfinger, James D., et al.
Publicado: (2009)

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
por: Dunbar, Albert, et al.
Publicado: (2020)

Treatment and Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
por: Smith, Don, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_enpq9qe0bn0t21t0bbsn4crike